16 Results for "

rat paw edema model

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "rat paw edema model" in MCE Product Catalog:

Cat. No.: HY-134521
CAS No.: 15362-40-0
Target:  

COX

Research Areas:  

Inflammation/Immunology

Diclofenac amide is a prodrug for Diclofenac sodium (HY-15037). Diclofenac amide is an orally active inhibitor for COX-1/2, that inhibits the production of prostaglandins (PG) and thromboxanes (TX). Diclofenac amide exhibits anti-inflammatory efficacy in Carrageenan (HY-125474)-induced rat paw edema model without causing gastric ulcer (300 μmol/kg) .
loading...
    loading...
Cat. No.: HY-124517
CAS No.: 34970-69-9
Burimamide is a blocker of histamine H2-receptor. Burimamide inhibits gastric acid secretion evoked by Pentagastrin (HY-A0261) or Gastrin. Burimamide also has alpha-adrenoceptor blocking activity. Burimamide in combination with the H1-receptor antagonist Mepyramine (HY-B1281) shows anti-inflammatory activity in a rat paw edema model induced by Compound 48/80 (HY-115768) .
loading...
    loading...
Cat. No.: HY-119298
CAS No.: 905285-51-0
Target:  

p38 MAPK

Research Areas:  

Inflammation/Immunology

AW-814141 is a selective and orally active p38 MAP kinase inhibitor. AW-814141 has an IC50 values of 100 nM and 158 nM for p38-α and β isoforms, respectively. AW-814141 can inhibit the production of TNF-α induced by LPS (HY-D1056). AW-814141 can inhibit paw edema in rats in a dose-dependent manner. AW-814141 exhibits anti-inflammatory activity and can be used in the research of inflammatory diseases such as rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-116873
CAS No.: 66934-18-7
Target:  

COX

Research Areas:  

Inflammation/Immunology

Flunoxaprofen is an orally active COX inhibitor. Flunoxaprofen shows anti-inflammatory activity in a rat paw edema model. Flunoxaprofen may be used in research on immune system diseases such as arthritis .
loading...
    loading...
Cat. No.: HY-155133
CAS No.: 2788578-71-0
Purity:  98.87%
Target:  

COX

Research Areas:  

Inflammation/Immunology

COX-2-IN-34 (compound 8a) is a selective and orally active inhibitor of COX-2 , with an IC50 of 0.42 μM. COX-2-IN-34 has no gastric ulcer toxicity but has anti-inflammatory effects .
loading...
    loading...
Cat. No.: HY-119279
CAS No.: 848837-33-2
Target:  

Histamine Receptor

Research Areas:  

Inflammation/Immunology

VUF 10214 is a H4 receptor ligand with a pKi of 8.25. VUF 10214 exhibits significant anti-inflammatory activity in a carrageenan-induced paw edema rat model and can be used for research in the field of inflammatory diseases .
loading...
    loading...
Cat. No.: HY-N8458
CAS No.: 10308-13-1
Synonyms: NSC 272693
Target:  

PGE synthase

Research Areas:  

Inflammation/Immunology

Cryogenine is an alkaloid originally isolated from H. salicifolia that has anti-inflammatory activity. It inhibits prostaglandin synthetase (IC50=424 μM). Cryogenine (100 mg/kg per day, p.o.) reduces paw edema and the mean arthritic index in a rat model of adjuvant-induced polyarthritis.
loading...
    loading...
Cat. No.: HY-147719
CAS No.: 1610894-92-2
Target:  

COX

Research Areas:  

Inflammation/Immunology

COX-2-IN-16 (compound 2b) is a potent, selective and orally active COX-2 inhibitor with an IC50 of 102 µM. COX-2-IN-16 inhibits the NO production. COX-2-IN-16 shows anti-inflammatory activity .
loading...
    loading...
Cat. No.: HY-W747879
Diclofenac Amide- 13C6 is the 13C-labeled Diclofenac amide (HY-134521). Diclofenac amide is a prodrug for Diclofenac sodium (HY-15037). Diclofenac amide is an orally active inhibitor for COX-1/2, that inhibits the production of prostaglandins (PG) and thromboxanes (TX). Diclofenac amide exhibits anti-inflammatory efficacy in Carrageenan (HY-125474)-induced rat paw edema model without causing gastric ulcer (300 μmol/kg) .
loading...
    loading...
Cat. No.: HY-179700
Target:  

COX

Research Areas:  

Inflammation/Immunology

COX-2-IN-61 is an orally active COX-2 inhibitor with an IC50 of 22 µM, also inhibits COX-1 with an IC50 of 43 µM. COX-2-IN-61 exhibits anti-inflammation effects in a Carrageenan (HY-125474) induced rat paw edema model, with promising safety profiles. COX-2-IN-61 can be used for the research of inflammation .
loading...
    loading...
Cat. No.: HY-180822
COX-2-IN-63 (Compound 6k) is an orally active COX-2 inhibitor with an IC50 of 0.89 μM. COX-2-IN-63 reduces the levels of inflammatory mediators PGE2, TNF-α, and IL-6. COX-2-IN-63 can effectively alleviate acute inflammation in a rat paw edema model and has a lower risk of gastrointestinal side effects. COX-2-IN-63 can be used in anti-inflammatory research .
loading...
    loading...
Cat. No.: HY-184709
COX-2-IN-69 is a selective, orally active COX-2 inhibitor with an IC50 of 0.82 μM. COX-2-IN-69 occupies the secondary pocket of COX-2, interacts with His90 and Arg513, and reduces the serum levels of PGE2, IL-1β and TNF-α. COX-2-IN-69 exerts anti-inflammatory activity in a rat paw edema model. COX-2-IN-69 can be used in inflammation-related research .
loading...
    loading...
Cat. No.: HY-184710
Research Areas:  

Inflammation/Immunology

COX-2-IN-69 is a selective, orally active COX-2 inhibitor with an IC50 of 0.90 μM. COX-2-IN-69 occupies the secondary pocket of COX-2, interacts with His90 and Arg513, and reduces serum levels of PGE2, IL-1β and TNF-α. COX-2-IN-69 exerts anti-inflammatory activity in a rat paw swelling model. COX-2-IN-69 can be used in inflammation-related research .
loading...
    loading...
Cat. No.: HY-181235
Target:  

COX Cytochrome P450

Research Areas:  

Inflammation/Immunology Cancer

COX-2/Aromatase-IN-1 is a potent dual inhibitor of COX-2 and aromatase. COX-2/Aromatase-IN-1 can simultaneously inhibit COX-2 and aromatase, significantly suppress inflammation and induce proliferation inhibition of breast cancer cells. COX-2/Aromatase-IN-1 exerts anti-breast cancer and anti-inflammatory effects in the MCF-7 breast cancer cell and carrageenan-induced rat paw edema model. COX-2/Aromatase-IN-1 can be used for the study of inflammation and breast cancer .
loading...
    loading...
Cat. No.: HY-181236
CAS No.: 1622452-45-2
Target:  

COX Cytochrome P450

Research Areas:  

Inflammation/Immunology Cancer

COX-2/Aromatase-IN-2 is a potent dual inhibitor of COX-2 and aromatase. COX-2/Aromatase-IN-2 can simultaneously inhibit COX-2 and aromatase, suppress inflammation and induce proliferation inhibition of breast cancer cells. COX-2/Aromatase-IN-2 exerts anti-breast cancer and anti-inflammatory effects in the MCF-7 breast cancer cell and carrageenan-induced rat paw edema model. COX-2/Aromatase-IN-2 can be used for the study of inflammation and breast cancer .
loading...
    loading...
Cat. No.: HY-187141
CAS No.: 69052-92-2
Target:  

COX

1,1,2-Triphenylhex-1-ene is an orally active COX-2 inhibitor with an IC50 of 7.9 μM against ovine COX-2. 1,1,2-Triphenylhex-1-ene attenuates inflammation by inhibiting COX-2. 1,1,2-Triphenylhex-1-ene relieves abdominal contractions. 1,1,2-Triphenylhex-1-ene can be used in research related to inflammation and pain .
loading...
    loading...
  • 1